Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging: Diagnostic Pathways and Metabolites for Renal Tumor Entities
暂无分享,去创建一个
A. Feuchtinger | A. Walch | W. Weichert | A. Buck | H. Moch | P. Schraml | N. Sun | M. Autenrieth | Verena M. Prade | F. Erlmeier | Thomas Kunzke | A. Hartmann | Jian Shen
[1] V. Copié,et al. Nuclear magnetic resonance and surface-assisted laser desorption/ionization mass spectrometry-based metabolome profiling of urine samples from kidney cancer patients. , 2020, Journal of pharmaceutical and biomedical analysis.
[2] Jialing Zhang,et al. Mass Spectrometry Imaging enables Discrimination of Renal Oncocytoma from Renal Cell Cancer Subtypes and Normal Kidney Tissues. , 2019, Cancer research.
[3] M. Attimonelli,et al. Papillary Renal Cell Carcinomas Rewire Glutathione Metabolism and Are Deficient in Both Anabolic Glucose Synthesis and Oxidative Phosphorylation , 2019, Cancers.
[4] K. Kinoshita,et al. Value of global metabolomics in association with diagnosis and clinicopathological factors of renal cell carcinoma , 2019, International journal of cancer.
[5] Eden L. Romm,et al. Recognition of early and late stages of bladder cancer using metabolites and machine learning , 2019, Metabolomics.
[6] M. Attimonelli,et al. Metabolic reprogramming and elevation of glutathione in chromophobe renal cell carcinomas , 2019, bioRxiv.
[7] Lorenzo Marconi,et al. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update. , 2019, European urology.
[8] V. Mootha,et al. Early loss of mitochondrial complex I and rewiring of glutathione metabolism in renal oncocytoma , 2018, Proceedings of the National Academy of Sciences.
[9] E. Reznik,et al. Impairment of gamma-glutamyl transferase 1 activity in the metabolic pathogenesis of chromophobe renal cell carcinoma , 2018, Proceedings of the National Academy of Sciences.
[10] David S. Wishart,et al. MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis , 2018, Nucleic Acids Res..
[11] David S. Wishart,et al. HMDB 4.0: the human metabolome database for 2018 , 2017, Nucleic Acids Res..
[12] M. Attimonelli,et al. Renal oncocytoma characterized by the defective complex I of the respiratory chain boosts the synthesis of the ROS scavenger glutathione , 2017, OncoTarget.
[13] A. Holmgren,et al. Redox Signaling Mediated by Thioredoxin and Glutathione Systems in the Central Nervous System. , 2017, Antioxidants & redox signaling.
[14] S. Williamson,et al. Modern Pathologic Diagnosis of Renal Oncocytoma , 2017, Journal of kidney cancer and VHL.
[15] B. Delahunt,et al. Diagnostic criteria for oncocytic renal neoplasms: a survey of urologic pathologists. , 2017, Human pathology.
[16] Michael Becker,et al. FDR-controlled metabolite annotation for high-resolution imaging mass spectrometry , 2016, Nature Methods.
[17] W. Weichert,et al. PD-1/PD-L1 expression in chromophobe renal cell carcinoma: An immunological exception? , 2016, Medical Oncology.
[18] Na Sun,et al. High-mass-resolution MALDI mass spectrometry imaging of metabolites from formalin-fixed paraffin-embedded tissue , 2016, Nature Protocols.
[19] P. Humphrey,et al. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. , 2016, European urology.
[20] Chris Sander,et al. An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma. , 2016, Cancer cell.
[21] D. Ribatti,et al. Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma , 2015, Oncotarget.
[22] H. Schlüter,et al. MALDI imaging on tissue microarrays identifies molecular features associated with renal cell cancer phenotype. , 2014, Anticancer research.
[23] E. Gazzano,et al. The pentose phosphate pathway: an antioxidant defense and a crossroad in tumor cell fate. , 2012, Free radical biology & medicine.
[24] E. Mikros,et al. (1)H NMR metabonomic analysis in renal cell carcinoma: a possible diagnostic tool. , 2010, Journal of proteome research.
[25] H. Moch,et al. Chromophobe Renal Cell Carcinoma: Histomorphologic Characteristics and Evaluation of Conventional Pathologic Prognostic Parameters in 145 Cases , 2008, The American journal of surgical pathology.
[26] Ximing J. Yang,et al. Renal oncocytoma with and without intravascular extension into the branches of renal vein have the same morphological, immunohistochemical and genetic features , 2008, Virchows Archiv.
[27] K. Sipos,et al. Maturation of Cytosolic Iron-Sulfur Proteins Requires Glutathione* , 2002, The Journal of Biological Chemistry.
[28] S. Tickoo,et al. Renal oncocytoma: a reappraisal of morphologic features with clinicopathologic findings in 80 cases. , 1999, The American journal of surgical pathology.
[29] A. Meister,et al. On the discovery of glutathione. , 1988, Trends in biochemical sciences.
[30] S. Srivastava,et al. Detoxification of xenobiotics by glutathione S‐transferases in erythrocytes: the transport of the conjugate of glutathione and 1‐chloro‐2,4‐dinitrobenzene , 1983, British journal of haematology.
[31] H. Krebs,et al. Regulation of the pentose phosphate cycle. , 1974, The Biochemical journal.
[32] Hiroyuki Ogata,et al. KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..